Clinical Trial Update: Montelukast in Very Low Birthweight Infants [Phase 1]

View source ↗

Summary

This clinical trial update reports completed Phase 1 results for using montelukast in very low birthweight infants with bronchopulmonary dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: COMPLETED